Soothing Relief For Dry, Irritated Eyes.

Due to its thicker formula, REFRESH® CELLUVISC® Lubricant Eye Drops is an ideal eye drop, for persistent dry eye conditions. REFRESH® CELLUVISC® restores the moisture your eyes crave, with a gentle protecting and lubricating formula that has some of the same healthy qualities as natural tears. So, you can enjoy long-lasting relief, from the irritating, scratchy feeling of dry, irritated eyes.

To avoid the use of potentially irritating preservatives found in some bottled eye drops, REFRESH® CELLUVISC® Lubricant Eye Drops comes in preservative-free, air-tight, single-use containers. So, you can apply REFRESH® CELLUVISC® as often as necessary, to provide 24-hour comfort.

Drug Facts

Active Ingredient:
Purpose:
Carboxymethylcellulose.....................................
sodium (CMC) 1.0%
Eye Lubricant

Uses

Warnings:

Stop use and ask a doctor if you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists, for more than 72 hrs.

Keep out of the reach of children. If swallowed, get medical help, or contact a Poison Control Center right away.

Other Information:

Inactive ingredients:

Calcium chloride, potassium chloride, purified water, sodium chloride, and sodium lactate.

How Supplied: REFRESH® CELLUVISC® (carboxymethylcellulose sodium) 1.0% Lubricant Eye Drops are supplied in sterile, preservative-free, disposable, single-use containers of 0.4 mL (0.01 fl. oz.) each, in the following size:

30 Sterile Single-Use Containers--NDC 0023-4554-30

®Marks owned by Allergan, Inc.

©Allergan, Inc.

Irvine, CA 92612

PRODUCT PHOTO(S):

NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug's identity should be verified by chemical analysis.

images/pills/o06103b3.jpg



Copyright© 2006 Thomson PDR